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(57)	 ABSTRACT
The method is used for separating nucleic acids and other
similar constructs. It involves selective introduction,
enhancement, or stabilization of affinity handles such as
single- strandedness in the undesired (or desired) nucleic
acids as compared to the usual structure (e.g., double-strand-
edness) of the desired (or undesired) nucleic acids. The
undesired (or desired) nucleic acids are separated from the
desired (or undesired) nucleic acids due to capture by meth-
ods including but not limited to immobilized metal affinity
chromatography, immobilized single-stranded DNA binding
(SSB) protein, and immobilized oligonucleotides. The inven-
tion is useful to: remove contaminating genomic DNA from
plasmid DNA; remove genomic DNA from plasmids, BACs,
and similar constructs; selectively separate oligonucleotides
and similar DNA fragments from their partner strands; puri-
fication of aptamers, (deoxy)-ribozymes and other highly
structured nucleic acids; Separation of restriction fragments
without using agarose gels; manufacture recombinant Taq
polymerase or similar products that are sensitive to host
genomic DNA contamination; and other applications.
12 Claims, 4 Drawing Sheets
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Figure 1: Removal of E. coli genomic DNA from pCMVsport-p-gal
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Figure 2: Predicted Secondary Structure of anti-VEGF aptamer
L
1	 (`
C\
C\	 1p
g--g--9 
A
7
Introduction of
affinity handles via
selective
denaturation/
renatu ration
Structured
aptamer
Vector backbone
Selective binding
to affinity column
Elution from column
U.S. Patent	 Feb. 22, 2011	 Sheet 3 of 4	 US 7,893,222 B2
Figure 3: Graphical Representation of Aptamer Purification Using
Introduction of Affinity Handles Followed by Affinity Capture
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Figure 4: General Purification Scheme for Introduction of Affinity Handles
Followed by Affinity Capture Using Heating and Quenching Followed by an
Affinity Column
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INTRODUCTION OF STRUCTURAL
AFFINITY HANDLES AS A TOOL IN
SELECTIVE NUCLEIC ACID SEPARATIONS
The present application claims priority of provisional U.S.
Ser. No. 60/434,901 filed 20 Dec. 2002. 
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
This invention was made with government support under
Cooperative Agreement NCC 9-58 awarded by NASA. The
government has certain rights in the invention.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the general field of bio-
chemical separations, generally classified in U.S. Patent
Class 435.
2. Description of the Prior Art
Advances in gene therapy, DNA vaccines and other DNA-
based therapeutics have increased the demand for large-scale
production of plasmid DNA and other circular constructs
such as bacterial artificial chromosomes (BACs) that are rela-
tively free of contaminants. In gene therapy, plasmid DNA-
based vectors are preferred over viral-based vectors because
they lack the issues specific to the viral vectors, such as the
difficulties with producing and purifying high viral titers,
viral vector-related toxicity, the possibility of insertion into
the human genome, and potential reversion to active viruses.
As these areas progress, there will be an increasing need for
large-scale production of these constructs in their efficacious
form that are free of genomic DNA and other contaminants
like irreversibly denatured plasmid and relaxed or nicked
plasmid isoforms. At least one investigator at the U.S. Food
and Drug Administration (FDA) has recommended a level of
no more than 10 nanograms of genomic DNA per human dose
for pharmaceutical grade DNA vaccines.
Genomic DNA contamination also can impair processes
used in the laboratory and in industry. For example, such
contamination can inhibit or obstruct polymerase chain reac-
tion (PCR) and sequencing reactions.
Several methods exist for the separation of DNA and other
nucleic acids, such as ion exchange chromatography, adsorp-
tion onto silica or glass beads in the presence of chaotropic
ions, electrostatic interaction with DEAE-cellulose mem-
brane paper, ligand exchange on metal-loaded cation
exchange resin, hydrophobic interaction chromatography,
hydroxyapatite adsorption, immobilized oligonucleotides,
and size exclusion chromatography (SEC).
Specific prior publications known to the inventors include
(1) Murphy, J. C.; Wibbenmeyer, J. A.; Fox, G. E.; Willson, R.
C. Nat Biotechnol 1999, 17, 822-823. (Does not include
selective Denaturation/Renaturation prior to IMAC bind-
ing)
(2)Prazeres, D. M.; Ferreira, G. N.; Monteiro, G. A.; Cooney,
C. L.; Cabral, J. M. Trends Biotechnol 1999, 17, 169-174.
Bimboim, H. C. Methods Enzymol 1983, 100, 243-255.
(Does not include the use of selective denaturation for
changing the conformational state of gDNA to allow selec-
tive sep. from plasmid DNA)
(3)Wetmur, J. G.; Davidson, N. JMolBiol 1968, 31, 349-370.
(Does not utilize the denatured DNA affinity handles)
(4) Marmur, J.; Doty, P. Journal of Molecular Biology 1961,
3, 585-594. (Does not include the use of selective renatur-
ation for purification)
2
(5) Viglasky, V.; Antalik, M.; Adamcik, J.; Podhradsky, D.
Nucleic Acids Res 2000, 28, E51. (does not include the use
of conformational stability of plasmid DNA in selective
denaturation/renaturation of genomic DNA in thepresence
5	 of plasmid)
(6)Willson, R. C.; Murphy, J. C. WO 02/46398 A2, published
Jun. 13, 2002. (Does not include selective denaturation
prior to binding)
(7) Bridonneau, P. B., Seve; Tengler, Robert; Hill, Ken;
10 Carter, Jeff; Pieken, Wolfgang; Tinnermeier, David; Lehr-
man, Russ; Drolet, Daniel W.; Journal of Chromatography,
B 1999, 726, 237-247. (Denaturing conditions are used
only to disrupt secondary structure, not to utilize it)
(8) Deregon, J. M. S., Daniel; Mitchell, Grant; Potier, Michel;
15	 Labuda, Damian Nucleic Acids Research 1990, 18, 6149.
(Does not use any type of affinity method, for the removal
of gDNA prior to PCR)
(9) Lima, W. F. American Biotechnology Laboratory 1988, 6,
20-22. (Uses the method of alkaline lysis to remove linear
^^	 and open-circle DNA, does not use selective affinity meth-
ods)
None of the above references is understood to teach the steps
of introducing affinity handles into certain desired (or undes-
25 ired) moieties, then using these handles to separate out
desired (or undesired) moieties.
3. Problems Presented by Prior Art
While there are several methods for separating DNA and
other nucleic acids, these techniques either lack appropriate
30 selectivity or desired capacity. For example, in the case of
genomic DNA removal, some separation methods, such as
hydroxyapatite adsorption or immobilized oligonucleotides,
do not readily achieve the selectivity needed to separate
genomic DNA from chemically similar plasmid DNA, or may
35 be too sequence specific to be generally applicable.
Other methods are only suitable for producing small
amounts of the desired nucleic acids. Anion exchangers have
difficulty separating plasmid DNA from genomic DNA frag-
40 
ments of similar affinity, and also generally have a low capac-
ity for nucleic acids. SEC has the disadvantages of low capac-
ity and dilution of the sample, leading to lower yields. SEC
also cannot easily remove genomic DNA fragments of a
broad size distribution, which could lead to the unwanted
45 co-elution of contaminant with the desired product.
These methods fail to achieve the necessary selectivity for
more general separations such as oligonucleotide separa-
tions, aptamer purification, restriction fragment isolation, and
other separations involving similar chemical species.
50 There is a need for a more selective method of separating
plasmid DNA or similar constructs from genomic DNA that
results in a relatively uncontaminated product in larger vol-
umes and yields than achieved with current separation meth-
ods. There is also a need for nucleic acid separations that
55 attain a selectivity that is not available with current methods.
These separations that require higher selectivity include
aptamer purification, separation of complementary strands of
DNA (one of which may be a functional DNA; e.g. aptamer,
deoxyribozyme), and rapid separation of restriction frag-
60 ments that are non gel-based.
SUMMARY OF THE INVENTION
Current methods for separating nucleic acids either lack
65 sufficient selectivity or large capacity production as required
for gene therapy or DNA vaccines or other applications.
There is a need for a more selective method of separating
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nucleic acids that results in arelatively uncontaminated prod-
uct in larger volumes and yields than achieved with currently
available separation methods.
The novel separation technique described herein addresses
these shortcomings. This method, which extends to, but is not
limited to a number of alternative structures and chemistries
for nucleic acids (for example, alternative backbone struc-
tures), involves the selective introduction, enhancement, sta-
bilization of structural "affinity handles" such as single-
strandedness in the undesired (or desired) nucleic acids as
compared to the usual structure, such as double-strandedness,
of the desired (or undesired) nucleic acids. The exposed bases
of single-stranded undesired (or desired) nucleic acids allow
capture of the undesired (or desired) nucleic acids by tech-
niques which are selective for single stranded regions of
nucleic acids, such as but not limited to immobilized metal
affinity chromatography (IMAC), hydrophobic interaction
chromatography (HIC), reversed-phase chromatography
(RPC), immobilized single-stranded DNA binding (SSB)
protein, immobilized nucleic acids (poly-dT, poly-dU, or spe-
cific sequences), or the use of peptide nucleic acids (PNAs).
We have shown that IMAC can selectively and efficiently
capture nucleic acids containing exposed purine bases and
separate them from the desired product. We have shown that
this method of introduction of affinity handles followed by
capture can be used to remove contaminating E. coli genomic
DNA from supercoiled plasmid. It can also remove other
circular constructs that are on a smaller order of size than, for
example, E. coli genomic DNA. Unlike anion exchangers,
only the trace contaminant is bound and the effective capacity
for the desired product is high.
Processes such as selective thermal denaturation and rena-
turation, alkaline denaturation, the use of restriction enzymes
yielding single-stranded overhangs, the use of oligonucle-
otide dTs, single-stranded DNA binding proteins, minerals,
and the use of primers or other nucleic acid fragments such as
complementary DNA are useful for introducing, enhancing,
or stabilizing affinity handles (e.g., single strandedness) in the
undesired (or desired) nucleic acids to facilitate capture and
separation of the undesired (or desired) nucleic acid from the
desired (or undesired) nucleic acids, carbohydrate or protein.
This technique can be used to remove unwanted nucleic
acid sequences that are already single-stranded, such as irre-
versibly denatured plasmids that have lost their supercoiled
nature or other nucleic acid fragments, and enhance the puri-
fication of the favored nucleic acid product or other product.
This novel separation method can be easily scaled up for
production of larger yields.
Any combination of techniques for introducing, stabiliz-
ing, or enhancing affinity handles and capturing the separated
results, which includes avariety of products, can beused. One
implementation of selective separation of nucleic acids uses
selective thermal denaturation and renaturation followed by
capture (e.g., by IMAC or other methods like immobilized
nucleic acids). Another implementation uses pH or other
chemical denaturation followed by capture (e.g., by IMAC).
This invention may be used to separate genomic DNA from
plasmid DNA or other circular constructs; to separate oligo-
nucleotides (and other similar nucleic acid fragments) from
their partner strands; to purify aptamers and other functional
nucleic acids from restriction fragments, PCR products, and
4
other DNA sources; or to purify proteins, carbohydrates or
other products from nucleic acids such as genomic DNA.
DETAILED DESCRIPTION OF INVENTION
In contrast to proteins, nucleic acids can tolerate reversible
modification of their conformations. This separation method
can take advantage of this characteristic of nucleic acids and
permits higher selectivity than would otherwise be achieved.
10 One implementation of selective separation of nucleic
acids uses selective renaturation with capture (e.g., capture
with IMAC) to remove contaminating genomic DNA from
plasmid DNA. Plasmid DNA quickly renatures after denatur-
ation and rapid cooling while genomic DNA remains partially
15 denatured upon rapid cooling. This partially denatured state
for genomic DNA is enhanced and stabilized with high ionic
strength buffer. A metal chelate matrix (IMAC) selectively
binds partially denatured genomic DNA through its exposed
purine bases; double-stranded renatured plasmid DNA is not
20 bound. This separation method can attain an eight-log clear-
ance of 30% E. coli genomic DNA (by weight) from samples
containing the plasmid pCMVsport-p-gal.
Another implementation for this separation method uses
alkaline denaturation, which is well suited for smaller labo-
25 ratory-scale separations. Other techniques are described
below in further detail.
Introducing Affinity Handles
Selective thermal denaturation and renaturation, alkaline
30 denaturation and the use of restriction enzymes yielding
single-stranded overhangs are all possible methods of intro-
ducing affinity handles. The resulting handles may be cap-
tured by the use of oligonucleotide dTs to capture single
stranded regions, single-stranded DNA binding proteins,
35 minerals, and the use of primers or other nucleic acid frag-
ments such as complementary DNA nucleic acids. The intro-
duced selectivity of affinity handles can facilitate capture and
separation of the undesired (or desired) nucleic acid from the
desired (or undesired) nucleic acids, such as open circular
40 (nicked) and linear. The introduction of affinity handles may
also be conveniently accomplished through other steps
already incorporated into a process, such as heat-based or
alkali-based microbial lysis of plasmid DNA. In the case of a
heat-based process, the exiting stream can be rapidly cooled
45 in order to form affinity handles on the contaminant (genomic
DNA) and then be captured by a suitable affinity method as
described below.
Selective Thermal Denaturation and Renaturation (e.g., for
50 Genomic DNA Removal)
Selective capture of denatured genomic DNA (e.g., by
IMAC) requires denaturation under conditions which either
minimally or reversibly denatures plasmid in its desired form
while converting genomic DNA into a form that can be
55 adsorbed, particularly as the higher temperatures used to
denature genomic DNA can adversely affect plasmid DNA's
ability to renature in the desired form.
A three-step process can accomplish the desired separa-
tion. The sample is heated in a heating buffer with little salt
60 (like sodium chloride) in the denaturation step. In the quench-
ing step, the sample is renatured at a lower temperature in a
quenching buffer that has higher ionic strength than the heat-
ing buffer. The unwanted nucleic acids are then separated by
techniques like IMAC, which captures nucleic acids with
65 single-stranded portions.
In the first step, heating denatures DNA, degrading
genomic DNA in particular, in a buffer with low ionic strength
US 7,893,222 B2
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or low salt concentration. Genomic DNA will denature at a
much higher temperature than plasmid DNA. This higher
denaturation temperature for genomic DNA can lead to high-
temperature scission of the plasmid DNA and to unusable
product. As nucleic acid melting temperature is strongly
dependent on the ionic strength of the solvent, denaturation in
low salt lowers genomic DNA melting temperature. The
lower heating temperature minimizes damage to plasmid
DNA from high-temperature scission.
The quenching step in a buffer with higher ionic strength
kinetically traps the genomic DNA in a partially denatured
state by stabilizing mismatched/non-specific base pairing.
The plasmid DNA is basically unaffected and will renature
substantially in its preferred supercoiled form. The higher
ionic strength of the quenching buffer also promotes IMAC
binding of the denatured genomic DNA in the next step.
In the last step, IMAC or other capture techniques remove
the undesired genomic DNA, irreversibly denatured plasmid
formed during heating, and traces of RNA. IMAC, presently
the best means of capturing the undesired nucleic acids, selec-
tively binds to exposed purine bases in partially denatured
genomic DNA, separating it from double-stranded renatured
plasmid DNA. A yield of about ninety percent (90%) recov-
ery of the total plasmid DNA in its desired supercoiled form
has been observed using IMAC. Other single/double-
stranded selective methods also apply for capture such as
hydroxyapatite adsorption or immobilized oligonucleotides.
The range of temperatures and heating time applicable to
selective thermal denaturation and renaturation may vary, but
the ideal temperatures are such that genomic DNA is effec-
tively degraded and denatured while avoiding significant
damage or irreversible denaturation for the desired nucleic
acid sequences in their desired forms. In other words, one
should operate in a temperature range above the melting
temperature of linear DNA (genomic DNA in this implemen-
tation), but below the temperature for the late helix-coil tran-
sition of the plasmid, when the two strands of the plasmid
molecule completely separate but are still topologically
linked. One should avoid the temperature for the late helix-
coil transition state for plasmid as it can lead to the formation
of irreversibly denatured plasmid DNA upon cooling. This
temperature range should also promote the desired denatur-
ation of genomic DNA regardless of the initial state of the
genomic DNA namely, whether it is sheared as compared to
intact.
The range of effective ionic strengths applicable for both
heating and quenching buffers will vary. The desired ionic
strength for the heating buffer should be sufficiently low so
that the melting temperature of genomic DNA in question is
reduced and the overall denaturation temperature can be low-
ered. At a lower denaturation temperature, high-temperature
scission damage to plasmid DNA can be minimized during
heating. The heating buffer should also be at an ionic strength
that does not promote scission of plasmid DNA at low ionic
strength. Similarly, the quenching buffer should be at an ionic
strength higher than the heating buffer such that plasmid
DNA renatures in its original form, but genomic DNA
remains partially denatured with exposed bases. At some
higher ionic strengths, binding of denatured genomic DNA to
IMAC is also promoted.
Alkaline Denaturation
Similar results to the thermal heat/quench method have
been achieved using an alkali denaturation scheme in con-
junction with IMAC for selective separation. The results are
similar to those derived from selective thermal denaturation
and renaturation. This alkali method may be well suited to
6
automation in small-scale, parallel operations, and closely
resembles the familiar alkaline lysis method of addition of
alkali solution followed by neutralization.
5 Other Affinity Handles
Structural forms such as Hairpins, Stems, Loops, Cruci-
forms, G quartets, single-stranded extensions and modifica-
tions to the phosphate backbone all constitute possible affin-
ity handles for capture.
10 Other Vectors
Selective separation of nucleic acids can also be used to
purify constructs other than supercoiled plasmid DNA. For
example, the method of heating and quenching followed by
IMAC can be used to remove genomic DNA from plasmids,
15 BACs, and similar constructs, provided that the size of the
construct is not on the order of the genome in question (e.g.,
E. Coli genomic DNA). The melting temperature of linear
DNA is generally above the temperature for the early helix-
coil transition in plasmids or other circular constructs, but
20 below the temperature for the late helix-coil transition. One
must only exceed the early helix-coil transition to effectively
denature degraded/linearized genomic DNA. The early helix-
coil transition is a function of a construct's superhelicity and
25 
is largely independent of size and sequence.
Other Applications:
Aptamer Purification and Separation of DNA Strands
The selective renaturation with capture technique can be
30 used to selectively separate oligonucleotides and similar
DNA fragments from their partner strands. In particular, this
method can be used to purify aptamers, small interfering
RNAs (siRNAs) and other functional DNAs from restriction
fragments, PCR products, or other nucleic acid sources. After
35 denaturation and rapid return to native conditions, a struc-
tured DNA such as an aptamer may form its structure before
finding its complementary strand. The resulting affinity
handles can be used for selective capture by IMAC or other
techniques.
40 Separation of Restriction Fragments
The invention can be used to separate restriction fragments
without using agarose gels. This separation from desired
insert fragments can be enhanced by the deliberate construc-
tion of repetitive complementary regions within a vector to
45 facilitate a selective conformational change in the undesired
backbone fragments. This technique also includes the delib-
erate introduction of "overhangs" in the restriction fragments
to facilitate selective binding and capture.
50 Removal of Non-Supercoiled Plasmid Isoforms from Super-
coiled Plasmid DNA
By using the selective denaturation/renaturation technique
described above, the invention can be used to remove plasmid
isoforms such as linear and open-circular (ocDNA) from
55 supercoiled plasmid. Because of differing thermodynamic
properties, the linear and ocDNA will exhibit thermodynamic
properties which will allow it to be selectively denatured, thus
exposing affinity handles in the form of exposed bases. The
isoforms can then be removed by a suitable affinity method as
60 described in this document.
Removal of Contaminating Genomic DNA from Recombi-
nant Taq Polymerase or Other Proteins or Products
This invention can be used in the manufacture of recombi-
65 nant Taq polymerase or similar products that are sensitive to
host genomic DNA contamination. For example, by introduc-
ing affinity handles in irreversibly denatured genomic DNA
US 7,893,222 B2
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during purification of the Taq polymerase, the genomic DNA 	 times with Milli-Q® grade water, then charged on a Roto-
can be removed by a capture method such as IMAC without	 Torque® rotator (Cole-Palmer) with 50 mM CuC1 2 (Acros)
affecting the product.
	
	 for one hour. Before use, the beads were washed three times
with water, then three times with 20 mM HEPES, 250 mM
DESCRIPTION OF DRAWINGS	 5 NaCl, pH 7.0.
For selective binding of genomic DNA in the presence of
FIG. 1 shows schematically removal of E. coli genomic	 plasmid, samples containing a mixture of pCMVsport R -gal
DNA from pCMVsport-(3-gal. Lane 1 is a supercoiled DNA	 and E. coli genomic DNA were prepared in 20 mM HEPES
ladder. Lane 2 is a pCMVsport-p-gal sample (20 µg) spiked 	 (no NaCI) as described above. The 50 µL sample was heated
with 8 µg E. coli genomic DNA (30% by weight genomic io at 80° C. for 1 minute and then flash cooled with one volume
DNA) in 20 mM HEPES (heating buffer). Lane 3 is the 	 (50 µL) of room temperature 20 mM HEPES, 500 mM NaCl.
sample from lane 2 heated at 80° C. for 1 minute followed by 	 This sample (100 µL) was then added to 50 µL of settled Cu
flash cooling with an equal volume of 20 mM HEPES, 500 	 (II)-IDA-agarose slurry and incubated at room temperature
mM NaCl (quenching buffer). Lane 4 is the sample in lane 3 	 on a rotator for one hour. The supernatant was next transferred
after four batch bindings with Cu (II)-IDA matrix (IMAC). 15 to an identical fresh tube of Cu (II)-IDA and equilibrated for
FIG. 2: shows schematically Predicted Secondary Struc- 	 one hour. This process was repeated twice more. The final
ture of anti-VEGF aptamer.	 supernatant was collected for electrophoresis and gPCR
FIG. 3: shows schematically a graphical Representation of 	 analysis. The Cu (II)-IDAbeads in both samples were washed
Aptamer Purification Using Introduction of Affinity Handles 	 and then eluted with 0.5 M imidazole in 20 mM HEPES, 250
Followed by Affinity Capture. A vector containing the desired 20 NaCl buffer overnight.
aptamer sequence is restricted using the appropriate 	 For E. coli genomic DNA quantitation, the Stratagene MX
enzymes. The mixture containing the sense-aptamer/anti- 	 4000 was used to carry out gPCR experiments. A TagMan®
sense aptamer plus vector backbone is then denatured via 	 probe sequence ((6FAM)-000CGTACACAAAAATGCA-
heat, alkali or other methods and quickly returned to native 	 CATGCTG-(6TAMRA); SEQ ID NO:1) and primer set
conditions to induce a conformational change in the aptamer 25 sequences (5'-GAAAGGCGCGCGATACAG-3' (SEQ ID
and anti-sense strand. The desired material canbe captured by 	 NO:2) and 3'-GTCCCGCCCTACTCATCGA-5' (SEQ ID
passing the mixture through an affinity column selective for 	 NO:3)) targeting the 7-copy E. coli 23S rRNA gene were
the desired aptamer strand. The aptamer is then eluted off the	 used. Qiagen's HotStarTaq MasterMix® PCR reagents were
column using the appropriate eluent. 	 used and the optimal primer ratio for the reaction was found
FIG. 4 shows schematically a General Purification Scheme 30 to be 5:1 (forward: reverse). A standard curve was constructed
for Introduction of Affinity Handles Followed by Affinity 	 between 100 fg and 1 ng of E. coli genomic DNA to quantitate
Capture Using Heating and Quenching Followed by anAffin-	 the final genomic DNA concentrations in experimental
ity Column. The sample is first passed through a heating loop 	 samples. The PCR cycle used was: 15 min at 95° C.; (12 min
of appropriate length to denature the sample. The sample is 	 at 94° C.; 1 min at 60° C.)x40.
next quenched with second buffer stream (top of figure) or 35 A yield of about ninety percent (90%) recovery of the total
passed through a second coil to rapidly cool the sample (bot- 	 plasmid DNA in its desired supercoiled form has been
tom of figure). The rapidly quenched sample is then passed 	 observed using selective thermal denaturation and renatur-
through an affinity column.	 ation with IMAC.
EXAMPLES	 40	 Example 2
Example 1	 Alkaline Denaturation
Selective Thermal Denaturation and Renaturation 	 A sample (20 µL) containing a mixture of pCMVsport
with Capture of Genomic DNA to Yield Plasmid 	 45 R -gal and E. coli genomic DNA was prepared as described
DNA
	
	
above in Example 1. 1.4 µL of a 1 M NaOH solution was
added and thoroughly mixed to bring the sample to a pH of
In this example, plasmid DNA was prepared as follows: E.	 12.3 (predicted by titration of 20 mM HEPES). The sample
coli 7M109 harboring the plasmid pCMVsport R -gal (7.9 kb,	 was incubated at room temperature for 5 minutes followed by
Gibco BRL) was cultured on LB medium containing kana- 5o addition of 1.9 µL of 0.5 M HCl, 2 M NaCl solution while
mycin (50 µg/ml). Shake flasks (4 L, containing 1 L LB) were	 mixing to rapidly neutralize the sample. This sample was then
incubated with shaking at 37° C. overnight, and cell mass was 	 added to 12 µL of settled Cu (II)-IDA-agarose slurry and
harvested by centrifugation at 1000xg for 30 min and frozen 	 incubated at room temperature on a rotator for one hour. The
at -80° C. Frozen cells (10 grams) were suspended in 100 ml 	 supernatant was next transferred to an identical fresh tube of
of 25 mM Tris, 10 mM EDTA, pH 8.0. The pellet was vigor-  55 Cu (II)-IDA and equilibrated for one hour. This process was
ously stirred at 4° C. for 30 minutes to ensure complete 	 repeated twice more. The final supernatant was collected for
re-suspension, which is essential for efficient lysis. The plas- 	 analysis by electrophoresis. The results obtained were similar
mid was extracted using alkaline lysis followed by purifica- 	 to Example 1.
tion using selective spermidine compaction precipitation.
Plasmid purity was verified by electrophoresis at 16 V/cm in 60	 Example 3
1 xTAE buffer on a 0.8% agarose gel containing SYBR gold
(Molecular Probes). Final plasmid and genomic DNA con-	 Purification of an Anti-VEGF Aptamer from
centrations were determined using a Beckman DU 7500 spec-	 Restriction Fragments Using IMAC with
trophotometer with unit absorbance at 260 nm corresponding 	 Ammonium Chloride Elution
to 50 µg DNA ml-'.	 65
Cu(II)-IDA beads (IMAC beads) were prepared as follows: 	 The sequence of the desired aptamer (5'CCG TCT TCC
chelating Sepharose FF® (Amersham) was washed three 	 AGA CAA GAG TGC AGG G 3') is inserted into a plasmid
US 7,893,222 B2
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(or other suitable vector) along with its double stranded part-
ner and expressed in the desired host organism. Following
standard DNA purification and endonuclease restriction, the
mixture is prepared in 20 mM HEPES buffer with no added
NaCl. The mixture is heated for 1 minute at 80° C. followed 5 Parameter
by rapid addition of one volume of 20 mM HEPES, 500 mM
NaCl in order to stabilize the aptamer in its stem-loop form
(FIG. 2). The sample is quickly loaded on to a Cu(II) charged
IMAC column to bind the single stranded regions of the 	 Affinity
structured aptamer and its complementary strand. After bind- 10 Handle
ing, a gradient of Ammonium Chloride (NH 3C1) or other
suitable eluent from 0 to 500 mM is passed through the
column in order to selectively separate the vector backbone
and the two strands from each other. For a continuous purifi-
cation scheme, the setup(s) in FIG. 4 can be used. 	 15
Example 4
Separation
Purification of an Anti-VEGF Aptamer from	 Step
Restriction Fragments Using an Oligonucleotide 	 20
Affinity Column
TABLE A-continued
Most
Preferred	 More Preferred	 Preferred
Single
strandedness,
double
strandedness,
Triplexes, Stem
or loop
structures
(hairpin),
Cruciform
structures
Affinity
capture
circular/linear plasmid
DNA, Host DNA
Single strandedness in Exposed
nucleic acids, base-pairs
hydrophobicity, on host
hydrophilicity genomic
DNA
Immobilized Purine-
oligonucleotides (specific selective
or non), Immobilized SSB IMAC with
protein, Immobilized various
metals, minerals, metal metals
affinity precipitation, metal
affinity electrophoresis,
pyrimidine-selective IMAC
Chromatography column, Filter plate
magnetic beads
The experiment proceeds as in Example 3 with the excep-
tion of the affinity column used. To capture the desired
aptamer after introduction of affinity handles, an affinity col- 25
umn is used that has immobilized oligonucleotides comple- 	 Separation Spin column,
mentary to a single stranded region of the desired aptamer 	 format magnetic
(e.g. 3' ACA GTC CCC 5'). The heated and quenched mixture beads,
is passed over the affinity column, selectively capturing the filter plate,
desired aptamer product. The product can then be eluted by a 30 chroma-
strong chaotropic salt, heat, or with low-salt buffer. tography
column,
Example 5	 electrophoresis,
microwell plate
Purification of DNA-Free Recombinant Taq 	 35 Denaturation Chaotropic	 Urea, Guanidine	 Thermal,
Polymerase	 Step	 Agents
	 Hydrochloride/Thiocyanate, Alkali pH
pH (low or high)
	A vector expressing Taq polymerase is harbored in an E.	 Thermal	 40-110° C.	 50-110° C./10-13 pH	 60-100° C./
	
coli strain and grown on the appropriate medium in batch or	 Denaturation **8-14
	 11-12.5 pH
continuous mode. The cells are harvested after 15-18 hours 40 temp/pH
and lysed via mechanical disruption in the presence of lysis	 gDNA level Undetectable less than 20
buffer (20 mM HEPES, 0.5% Brij 58). The lysate is clarified	 after	 by	 picograms/microgram
to remove particulate material and cell debris. The clarified 	 purification electrophoresis plasmid DNA
lysate is then heated at 80° C. for 1 minute followed by 	 or gPCR
quenching in an equal volume of high salt buffer (20 mM 45
HEPES, 500 mM NaCI). The mixture is then passed over an
IMAC column charged with Cu(II) to remove contaminating
nucleic acids, including denatured E. coli genomic DNA.
Standard protein purification steps are then carried out to
isolate the Tagpolymerase from other proteins in the lysate.A 50
scheme like FIG. 4 can be used for continuous removal of
MODIFICATIONS
less than 8
picograms
gDNA per
microgram
of Plasmid
DNA
genomic DNA.	 Specific compositions, methods, or embodiments dis-
TableA shows preferred values for some of the parameters of
the invention.
TABLE A
Most
Parameter	 Preferred	 More Preferred	 Preferred
Product	 Nucleic Acid, Oligonucleotides, Circular Supercoiled
Recombinant DNA constructs, Structured Plasmid
Protein, RNA DNA,
carbohydrate BACs,
PACs,
YACs
Contaminant	 Nucleic Acids, Oligonucleotide sense or Host DNA
rRNA anti-sense strand, Open (Genomic)
cussed are intended to be only illustrative of the invention
disclosed by this specification. Variations on these composi-
55 tions, methods, or embodiments are readily apparent to a
person of skill in the art based upon the teachings of this
specification and are therefore intended to be included as part
of the inventions disclosed herein.
60 Also it will be obvious to skilled persons that products
and/or separation step techniques than other those recited
herein may be used to great advantage in specific applications
of the invention.
65 Reference to documents made in the specification is intended
to result in such patents or literature being expressly incor-
porated herein by reference.
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 4
<210> SEQ ID NO 1
<211> LENGTH: 26
<212> TYPE: DNA
<213> ORGANISM: Escherichia coli
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (1)..(1)
<223> OTHER INFORMATION: modified by FFAM dye
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (26)..(26)
<223> OTHER INFORMATION: modified by 6TAMRA dye
<400> SEQUENCE: 1
ccccgtacac aaaaatgcac atgctg
<210> SEQ ID NO 2
<211> LENGTH: 18
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: TagMan probe
<400> SEQUENCE: 2
gaaaggcgcg cgatacag
<210> SEQ ID NO 3
<211> LENGTH: 19
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: primer sequence
<400> SEQUENCE: 3
gtcccgccct actcatcga
26
18
19
<210> SEQ ID NO 4
<211> LENGTH: 26
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: aptamer
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (1)..(1)
<223> OTHER INFORMATION: 6FAM dye
<220> FEATURE:
<221> NAME/KEY: misc_feature
<222> LOCATION: (26)..(26)
<223> OTHER INFORMATION: modified by 6TAMRA
<400> SEQUENCE: 4
ccccgtacac aaaaatgcac atgctg	 26
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What is claimed is:
1.A method for separating a polymerase from nucleic acid
in a sample comprising:
treating the sample to expose purine bases present in the 5
nucleic acid by a process selected from the group con-
sisting of thermal denaturation, alkaline denaturation
and restriction enzyme digestion yielding single-
stranded overhangs;
capturing the exposed purine bases of the nucleic acid on a 10
metal chelate matrix, wherein the polymerase does not
bind the metal chelate matrix;
separating the polymerase from the metal chelate matrix;
and
recovering the polymerase, thereby separating the poly- 15
merase from the nucleic acid.
2. The method of claim 1 wherein the polymerase is a
thermostable polymerase.
3. The method of claim 2 wherein the polymerase is Taq
polymerase.
14
4. The method of claim 1 wherein the nucleic acid is
genomic DNA.
5. The method of claim 1 wherein the sample is a cell
lysate.
6. The method of claim 1 wherein the separation is
achieved using multi-channel plates.
7. The method of claim 1 wherein the separation is
achieved using magnetic particles.
8. The method of claim 1 wherein multiple samples are
treated in parallel fashion.
9. The method of claim 1 wherein the metal chelate matrix
comprises Cu(II).
10. The method of claim 1 wherein exposing is performed
by thermal denaturation followed by quenching in a salt
buffer.
11. The method of claim 10 wherein the salt buffer com-
prises 20 mM HEPES and 500 mM NaCl.
12. The method of claim 1 wherein exposing is performed
by thermal denaturation followed by cooling.
